Treatment of cells expressing mutant Htt or alpha-synuclein, which are mutated in HD and Parkinson's disease (PD), respectively, with a cytoplasmic dynein inhibitor caused inhibition of the clearance of both aggregate-prone proteins by autophagy [63]. Here, SNCA is linked to Parkinson disease.